Related Experiment Video
Updated: Jul 4, 2026
07:42
Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
Published on: November 26, 2015
Increased expression of NKX3.1 in benign prostatic hyperplasia
Bora Irer1, Asli Toylu, Guven Aslan
1Department of Urology, Dokuz Eylul University, Inciralti, Izmir, Turkey.
Urology
|July 4, 2008
Summary
NKX3.1 gene expression, both messenger ribonucleic acid (mRNA) and protein, is significantly elevated in benign prostatic hyperplasia (BPH) tissues compared to normal prostate tissues. This suggests NKX3.1 plays a role in BPH development.
Area of Science:
- Urology
- Molecular Biology
- Genetics
Background:
- Benign prostatic hyperplasia (BPH) is a common condition affecting aging men.
- The molecular mechanisms underlying BPH development are not fully understood.
- NKX3.1 is a homeobox gene with known roles in prostate development and function.
Purpose of the Study:
- To investigate the role of the NKX3.1 gene in BPH development.
- To compare NKX3.1 messenger ribonucleic acid (mRNA) and protein expression in normal prostate and BPH tissues.
Main Methods:
- Quantitative reverse transcriptase polymerase chain reaction (RT-PCR) for mRNA analysis.
- Western blotting and immunohistochemistry for protein analysis.
- Comparison of tissues from young adult males (normal) and BPH patients.
Main Results:
- NKX3.1 mRNA levels were significantly higher in BPH tissues (19.17 +/- 3.05) versus normal tissues (1.24 +/- 1.32).
- NKX3.1 protein expression was approximately 2.4-fold higher in BPH tissues.
- Immunohistochemistry confirmed widespread NKX3.1 expression in BPH tissues, with no instances of absence.
Conclusions:
- NKX3.1 expression is upregulated in BPH tissues.
- Elevated NKX3.1 may be a key factor in the pathogenesis of BPH.
- Further research into NKX3.1's role could lead to new therapeutic strategies for BPH.
